Altimmune names Richard Menziuso principal accounting officer, global controller VP
ALT•Altimmune appointed Richard Menziuso vice president, global controller and principal accounting officer, effective Sept. 29, 2026.
1. Appointment
Menziuso previously served as vice president, corporate controller at Centessa Pharmaceuticals from 2021 until its 2026 acquisition by Eli Lilly. Earlier finance leadership roles included positions at Thermo Fisher Scientific, Axovant Gene Therapies, PricewaterhouseCoopers and Bristol-Myers Squibb.
